The company has already signed a distribution agreement with GE Medical Systems.
Medical device company WideMed Ltd. (TASE:WDMD) has won US Food and Drug Administration (FDA) approval to market its Noga system in the US. The Noga is a software program for monitoring sleep disorders in intensive care patients, on the basis of information gathered by the monitoring systems to which the patients are connected.
An FDA approval for a medical device does not always translate into immediate sales, but WideMed has made advance preparations by signing an agreement with General Electric Co. (NYSE: GE) subsidiary GE Medical Systems Information Technologies Inc. for the integration of the Noga system in GE Medical Systems Information Technologies Inc.'s own intensive care systems. If WideMed's software is installed in all of the GE unit's existing intensive care systems, it will generate tens of millions of dollars in revenue for the company, although such a process will obviously take time to complete.
Published by Globes [online], Israel business news - www.globes.co.il - on June 18, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007